Full Text PDF Share on Facebook Share on Twitter
Author Details:
Volume : 2
Issue : 2
Online ISSN : 2581-5016
Print ISSN : 2581-5024
Article First Page : 148
Article End Page : 151
Abstract
Bisphosphonates are drugs broadly disseminated and frequently used in clinical practice. Ocular adverse effects are already known and orbital inflammation outstands as one of the most severe. It is clinically evident by palpebral edema, conjunctival congestion, chemosis, ocular motility impairment, pain, diplopia, and blurred vision. It can affect both eyes and be accompanied by anterior uveitis. Timely treatment is vital to expect a favorable outcome. Systemic corticosteroids are the treatment of choice. We present the case of a patient whose inflammation improved after treatment with oral doses of diclofenac